CompoAtlas

Flora Natura® Vinaigre de Cidre BIO gélules

Food supplement declared in France, decision dated 12 June 2026

Flora Natura® Vinaigre de Cidre BIO gélules, from Scientia Natura Distribution, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Vinaigre de cidre. None of the rules we check flags an issue with its declared composition.

Brand
Flora Natura®
Food business operator placing the product on the market
Scientia Natura Distribution
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
3 gélules par jour
Directions for use
Prendre 3 gélules par jour le matin de préférence.
Intended populations
General population
Objectives stated by the manufacturer (these are not authorised claims)
Detox / Drainage

Declaration 367656, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Other active ingredients

NamePer day
Vinaigre de cidrenot declared

Additives

E464, E414

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Flora Natura®

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Flora Natura® Vinaigre de Cidre BIO gélules: composition and regulation”, https://compoatlas.com/en/supplements/products/367656-flora-natura-vinaigre-de-cidre-bio-gelules, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line